Pathogenesis of Pulmonary Arterial Hypertension

作者: Aaron W. Trammell , Anna R. Hemnes

DOI: 10.1007/978-1-4939-2636-7_3

关键词: BioinformaticsThrombosisPathophysiology of hypertensionDiseaseBMPR2MedicineRare diseaseVascular diseaseInflammationPathogenesis

摘要: Pulmonary arterial hypertension (PAH) is a rare disease of the pulmonary vasculature characterized by progressive vascular obliteration, right heart failure, and ultimately death. Basic science has focused for past several decades on identification underlying molecular causes this disease, multiple potential derangements have been identified some led to development drugs treat PAH. Unfortunately, however, there no cure PAH research continues identify common mechanisms develop new, more effective therapies. This chapter highlights much our understanding basic pathobiology including genetic underpinnings, vasoactive substances, alterations in cell proliferation apoptosis, inflammation, thrombosis, endocrine factors.

参考文章(207)
Danny Jonigk, Heiko Golpon, Clemens L. Bockmeyer, Lavinia Maegel, Marius M. Hoeper, Jens Gottlieb, Nils Nickel, Kais Hussein, Ulrich Maus, Ulrich Lehmann, Sabina Janciauskiene, Tobias Welte, Axel Haverich, Johanna Rische, Hans Kreipe, Florian Laenger, Plexiform Lesions in Pulmonary Arterial Hypertension The American Journal of Pathology. ,vol. 179, pp. 167- 179 ,(2011) , 10.1016/J.AJPATH.2011.03.040
James West, Cross Talk Between Smad, MAPK, and Actin in the Etiology of Pulmonary Arterial Hypertension Advances in Experimental Medicine and Biology. ,vol. 661, pp. 265- 278 ,(2010) , 10.1007/978-1-60761-500-2_17
Friedrich Grimminger, Ralph Theo Schermuly, PDGF receptor and its antagonists: role in treatment of PAH. Advances in Experimental Medicine and Biology. ,vol. 661, pp. 435- 446 ,(2010) , 10.1007/978-1-60761-500-2_28
P. D. Sampaio-Barros, C. Moreira, R. Moraes Torres, A. B. Cordeiro De Azevedo, Prevalence of pulmonary hypertension in systemic sclerosis Clinical and Experimental Rheumatology. ,vol. 23, pp. 447- 454 ,(2005)
Mariarosaria Bucci, Jean-Philippe Gratton, Radu Daniel Rudic, Lisette Acevedo, Fiorentina Roviezzo, Giuseppe Cirino, William C Sessa, None, In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation Nature Medicine. ,vol. 6, pp. 1362- 1367 ,(2000) , 10.1038/82176
FM Hofman, AD Wright, MM Dohadwala, F Wong-Staal, SM Walker, Exogenous tat Protein Activates Human Endothelial Cells Blood. ,vol. 82, pp. 2774- 2780 ,(1993) , 10.1182/BLOOD.V82.9.2774.2774
Brian B. Graham, Margaret M. Mentink-Kane, Hazim El-Haddad, Shawn Purnell, Li Zhang, Ari Zaiman, Elizabeth F. Redente, David W.H. Riches, Paul M. Hassoun, Angela Bandeira, Hunter C. Champion, Ghazwan Butrous, Thomas A. Wynn, Rubin M. Tuder, Schistosomiasis-Induced Experimental Pulmonary Hypertension : Role of Interleukin-13 Signaling American Journal of Pathology. ,vol. 177, pp. 1549- 1561 ,(2010) , 10.2353/AJPATH.2010.100063
Kirk B Lane, Rajiv D Machado, Michael W Pauciulo, Jennifer R Thomson, John A Phillips, James E Loyd, William C Nichols, Richard C Trembath, None, Heterozygous germline mutations in BMPR2 , encoding a TGF-β receptor, cause familial primary pulmonary hypertension Nature Genetics. ,vol. 26, pp. 81- 84 ,(2000) , 10.1038/79226
R. M. Tuder, N. F. Voelkel, D. B. Badesch, B. Groves, Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension American Journal of Pathology. ,vol. 144, pp. 275- 285 ,(1994)